Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Assessment of residual risk of atherosclerotic CVD according to serum TG and HDL-cholesterol levels and role of fenofibrate in the residual risk reduction in T2DM
Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Kim, Nam Hoon | - |
| dc.date.accessioned | 2021-08-28T00:43:50Z | - |
| dc.date.available | 2021-08-28T00:43:50Z | - |
| dc.date.created | 2021-04-22 | - |
| dc.date.issued | 2018-04-20 | - |
| dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/19681 | - |
| dc.publisher | Korean Endocrine Society | - |
| dc.title | Assessment of residual risk of atherosclerotic CVD according to serum TG and HDL-cholesterol levels and role of fenofibrate in the residual risk reduction in T2DM | - |
| dc.title.alternative | Assessment of residual risk of atherosclerotic CVD according to serum TG and HDL-cholesterol levels and role of fenofibrate in the residual risk reduction in T2DM | - |
| dc.type | Conference | - |
| dc.contributor.affiliatedAuthor | Kim, Nam Hoon | - |
| dc.identifier.bibliographicCitation | The 6th Seoul International Congress of Endocrinology and Metabolism | - |
| dc.relation.isPartOf | The 6th Seoul International Congress of Endocrinology and Metabolism | - |
| dc.relation.isPartOf | SICEM abstract book | - |
| dc.citation.title | The 6th Seoul International Congress of Endocrinology and Metabolism | - |
| dc.citation.conferencePlace | KO | - |
| dc.citation.conferenceDate | 2018-04-19 | - |
| dc.type.rims | CONF | - |
| dc.description.journalClass | 2 | - |
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medical Science > 2. Conference Papers
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.